Bioorthogonal catalytic activation of Platinum and Ruthenium anticancer complexes by FAD and flavoproteins by Alonso de Castro, S. et al.
German Edition: DOI: 10.1002/ange.201800288Prodrugs Very Important Paper
International Edition: DOI: 10.1002/anie.201800288
Bioorthogonal Catalytic Activation of Platinum and Ruthenium
Anticancer Complexes by FAD and Flavoproteins
Silvia Alonso-de Castro, Aitziber L. Cortajarena, Fernando Llpez-Gallego,* and Luca Salassa*
Abstract: Recent advances in bioorthogonal catalysis promise
to deliver new chemical tools for performing chemoselective
transformations in complex biological environments. Herein,
we report how FAD (flavin adenine dinucleotide), FMN
(flavin mononucleotide), and four flavoproteins act as uncon-
ventional photocatalysts capable of converting PtIV and RuII
complexes into potentially toxic PtII or RuII@OH2 species. In
the presence of electron donors and low doses of visible light,
the flavoproteins mini singlet oxygen generator (miniSOG)
and NADH oxidase (NOX) catalytically activate PtIV prodrugs
with bioorthogonal selectivity. In the presence of NADH, NOX
catalyzes PtIV activation in the dark as well, indicating for the
first time that flavoenzymes may contribute to initiating the
activity of PtIV chemotherapeutic agents.
The latest advances in bioorthogonal chemistry[1] demon-
strate how organometallic compounds and inorganic materi-
als are capable of catalyzing the activation of profluorescent
substrates and prodrugs with remarkable efficiency in bio-
logical environments.[2–10] These selective catalysts carry out
non-natural reactions dodging the interference of biological
molecules, in some cases with endogenous cellular compo-
nents as co-reactants.[3, 9]
In this context, we recently reported a new bioorthogonal
reaction in which riboflavin photoactivates a PtIV prodrug in
a catalytic process under irradiation with extremely low doses
of blue light and in the presence of zwitterionic electron
donors. Light activation of the riboflavin–prodrug pair
triggers cisplatin-related antiproliferative activity in PC3
cancer cells.[11] Unlike in classic organometallic catalysis,
where metals act as catalysts, in this reaction, the metal
complex is an unconventional substrate,[12] and the biocom-
patible riboflavin acts as catalyst.
Herein, we report fundamental discoveries in this new
area of bioorthogonal chemistry by 1) investigating the
catalytic behavior of various flavin catalysts, including four
flavoproteins with diverse biological functions and flavin
binding pockets, 2) increasing the pool of inorganic reactions
to different PtIV and RuII prodrug complexes, and 3) evaluat-
ing the efficiency of different (bio)organic electron donors
(Figure 1). Furthermore, our work shows for the first time
that certain flavoproteins may be directly implicated in the
activation of metallodrugs under biologically relevant con-
ditions in the absence of light.
Initially, we investigated the capability of FAD (flavin
adenine dinucleotide) to act as a catalyst for the photo-
activation of two classes of anticancer metal complexes,
namely octahedral PtIV and RuII–arene piano-stool com-
plexes. Complexes 1–3 are prodrugs of cisplatin and carbo-
platin,[13] and complexes 4 and 5 are photoactivatable
scaffolds capable of generating reactive Ru@OH2 species
that can bind to biomacromolecules (Figure 2a).[14–17] Impor-
tantly, these PtIV and RuII complexes have poor absorption
properties in the visible region (Figure 2b) compared to other
photoactivatable complexes, such as Ru polypyridyl species.
Therefore, novel strategies to prompt their photochemistry at
longer wavelengths are pivotal for their use in photochemo-
therapy. Complexes 1–5 are stable towards hydrolysis in the
dark, and have either no or poor photoreactivity under blue
light excitation.[11, 17,18]
FAD photocatalysis towards 1–5 was performed employ-
ing 10 mm of catalyst and 200 mm of metal substrate (5%
catalyst loading). In all irradiation experiments, we used an
LED light source (6 mWcm@2) with an emission maximum at
460 nm and 1H NMR analysis to monitor and quantify the
evolution of the photoreactions. The experimental methods
and a complete set of dark and light-irradiation experiments
are described in the Supporting Information (Figures S1–
S76).
First, we evaluated the effect of electron donors on the
catalytic process using complex 1, with the aim of optimizing
the reaction conditions. Three concentrations (0.2, 2, and
20 mm) of MES (as buffer, pH 6) or NADH in phosphate
buffer (PB, pH 7, 100 mm) were employed for this purpose.
MES was selected as an electron donor to follow up our
previous work on riboflavin[11] while NADH was chosen for
its relevance as a biological cofactor in numerous reactions
catalyzed by flavoenzymes.[19] Moreover, metal-based cata-
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lytic drugs have been recently shown to kill cancer cells by
interfering with cellular NAD+/NADH homeostasis.[20–22]
Upon 460 nm light excitation, FAD photoconverted the
PtIV substrate, and the catalytic efficiency increased linearly
with the MES concentration. FAD was fully inactive in the
dark at any tested MES concentration. In the absence of light,
0.2 or 2 mm NADH did not induce any reaction for 1, whereas
light irradiation switched on the generation of photoproducts
at 2 mm NADH when FAD was present. At 2 mm NADH,
FAD photocatalyzed the full conversion of 1 in only 2.5 min
whereas a reaction time of 5–10 min was required with 20 mm
MES. At the lowest concentration (0.2 mm), NADH was
instantaneously photooxidized to NAD+ by molecular oxygen
(O2), precluding any catalytic reaction between FAD and the
complex. Conversely, reduction of 1 at 20 mm NADH took
place readily in the dark when FAD was present, or under
light irradiation when the flavin was absent (Figures S1–S8).
Based on these results, we used 20 mm MES and 2 mm
NADH to determine the photocatalytic activity of FAD
towards 1–5 (Figure 2).[23] All complexes underwent photo-
chemical activation in the presence of catalytic quantities of
FAD (Figures S1–S38). In line with their redox chemistry in
biological contexts,[24] FAD photoactivation of 1–4 with
NADH was approximately twice as fast as that with MES.
The only exception was 5, for which the FAD turnover
frequency (TOF) was 3.4 times lower with NADH than with
MES (Table 1).
Kinetic analysis of these catalytic reactions showed that
the rate clearly depended on the nature of the substrate.
Complexes 1, 2, and 4 were the best substrates, giving the
highest TOFs and total turnover numbers (TTNs). Remark-
ably, FAD enabled the quantitative conversion of 1 and 2 into
the corresponding photoproducts regardless of the electron
donor used.
With FAD, a convenient excitation wavelength (460 nm)
and an extremely low light dose were employed for the
Figure 1. Structures of the catalysts, substrates, and electron donors employed in this study and proposed catalysis mechanism.
Figure 2. a) Flavin-mediated photoactivation reactions of complexes
1–5. b) Absorption spectra of FAD and 1–5.
Table 1: Turnover frequencies (TOFs, min@1) and total turnover numbers
(TTNs) for the FAd- and flavoprotein-catalyzed photoactivation of
complexes 1–5 in the presence of MES and NADH.
Complex MES (20 mm) NADH (2 mm)[a]
TOF TTN Conv. [%] TOF TTN Conv. [%]
FAD
1 2.3:0.2 20 100 5.0:1.7 20 100
2 4.0:0.5 20 100 7.1:1.8 20 100
3 0.6:0.1 11 55 2.3:0.6 14 70
4 4.5:0.6 16 80 9.0:2.3 20 100
5 2.2:0.5 16 80 0.6:0.1 14 70
miniSOG
1 1.0:0.2 20 100 7.1:0.4 20 100
2 1.2:0.1 20 100 8.6:2.2 20 100
NOX
1 0.62:0.01 20 100 4.3:1.6[b] 20 100
2 4.7:1.2 20 100 8.3:1.6[b] 20 100
GOX
1 not active
2 <0.1 5 20 <0.2 7.4 37
GR[a]
1 <0.1 10 50 0.42:0.07 20 100
2 not active 1.2:0.3 20 100
[a] Experiments for GR were run using NADPH. [b] In the dark.
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photoactivation of 1–5. In the case of 1, 2, and 4, a light dose of
about 1 J cm@2 was sufficient to fully convert the complexes
into their activated photoproducts. RuII–arene derivatives
such as 4 and 5 typically require irradiation times exceeding
one hour to reach about 50 % conversion (Figures S24 and
S32).[14–17] Herein, we show that less than 15 min are sufficient
to achieve comparable effects in 4 and 5 when FAD is used as
photocatalyst.
In cells, flavins are bound to proteins through covalent
and non-covalent interactions,[19] which control their (photo)-
redox properties.[24] Exploiting flavoproteins as selective
catalysts is therefore an exciting prospect for the design of
bioorthogonal activation strategies for metal-based prodrugs.
Accordingly, we selected four flavoproteins for their diverse
flavin-binding pockets and explored their capacity to catalyze
the photoreduction of 1 and 2. This part of the study was
limited to these derivatives for their relevance as anticancer
compounds[13, 25] with respect to the RuII complexes 4 and 5.
Furthermore, FAD displayed superior activity towards these
PtIV substrates compared to 3. The use of 2 was also aimed at
gauging the impact of the charge of the substrates on catalysis,
with this complex featuring a neutral alkyl chain at the axial
position rather than a negatively charged succinate as in 1.
The flavoprotein catalysts tested were miniSOG (mini
singlet oxygen generator),[26] NOX (NADH oxidase from
Thermus thermophilus),[27] GOX (glucose oxidase from
Aspergillus niger),[28] and GR (glutathione reductase from
S. cerevisiae).[29] MiniSOG is a flavin mononucleotide (FMN)
containing small protein investigated as a genetically encod-
able photosensitizer for the selective generation of singlet
O2.
[30–32] The bacterial NOX enzyme generates hydrogen
peroxide (H2O2) from O2 by oxidizing NADH while the
eukaryotic GOX naturally oxidizes glucose to H2O2 and
d-glucono-d-lactone. NOX and GOX have both been widely
exploited in biocatalysis.[27,33] GR is a NADPH-dependent
oxidoreductase exerting a central role in glutathione metab-
olism for most aerobic organisms.[34] GR was selected because
unlike other flavoproteins, it does not generate reactive
oxygen metabolites.
Different chemical environments surround the flavin-
binding pockets in these four flavoproteins, controlling
solvent and substrate accessibility to the active site. As
shown in Figure 3, the flavins are more exposed in min-
iSOG[35] and NOX than in GOX and GR, in which FAD is
deeply buried in the protein scaffold. The solvent-accessible
surface areas of the flavins are 45.50 c2 for miniSOG and
67.92 c2 for NOX, but only 2.39 c2 for GOX and 4.01 c2 for
GR. Moreover, they display different electrostatic surfaces in
the proximity of the flavin-binding pocket (Figures S39–S43).
At pH 6–7, the NOX and GR active sites are neutral, whereas
miniSOG and GOX display positive and negative electro-
static charges, respectively.
Unless otherwise stated, photocatalysis experiments (Fig-
ures S44–S76) were performed by employing 10 mm of the
flavoprotein catalysts, 200 mm of 1 or 2, and either 20 mm MES
or 2 mm NADH to directly compare the activities with that of
free flavin under the same conditions. The concentrations of
flavins bound to proteins were calibrated by optical methods
according to the FAD and FMN (for miniSOG) absorbance at
460 nm. Catalysis results for flavoproteins are summarized in
Table 1.
As anticipated from inspecting their flavin active sites,
GOX and GR showed the lowest catalytic activity towards
the PtIV substrates. GOX presented no catalytic activity
towards 1 under all of the experimental conditions tested.
There was also no activity when glucose (20 mm), a natural
substrate for the enzyme, was employed as a source of
electrons instead of MES or NADH. Conversion of 2 by GOX
occurred in the presence of both electron donors but the
reactions were slow and did not reach completion after 1 h of
light irradiation (conversion < 40%). With MES, GR was
poorly or not active towards 1 and 2. On the contrary, the use
of NADPH led to significantly higher TOF values and
complete substrate conversion within a few minutes of light
exposure.
With MES, miniSOG and NOX converted 1 and 2
exclusively into their photoproducts upon blue light excita-
tion. Whereas miniSOG showed no preference between the
two substrates, NOX was about seven times more reactive
towards 2 than towards 1. Light irradiation also switched on
the catalytic activity of miniSOG in PB/NADH. The flavo-
protein achieved full conversion of 200 mm 1 and 2 in about
4 min. In the case of 1, it is approximately five times less
efficient than free FMN (TOF = 35.6: 4.3 min@1; Figure S50).
To our surprise, NOX behaved differently, activating
1 and 2 in the dark when co-incubated with 2 mm NADH.
Under these conditions, 10 mm NOX completely converted
1 in less than 7.5 min while free FAD did not give any reaction
with 1 over 3 h (see above). The TOF values of 1 and 2 for
NOX were estimated to be 4.3: 1.6 min@1 and 8.3:
1.6 min@1, respectively, using less than 2 mm of the flavopro-
tein to allow for NMR reaction monitoring.
The discovery of NOX catalytic activity in the dark has
broad relevance for understanding the mechanism of action
of PtIV anticancer agents. It is a common assumption that PtIV
complexes are converted into active species by biological
molecular reductants, such as glutathione or ascorbic acid,
under physiological conditions.[37] Nevertheless, NOX-cata-
lyzed activation of 1 and 2 in the presence of 2 mm NADH is
rapid and suggests that flavoproteins can provide alternative
and highly efficient activation pathways for metallodrugs.[38]
Figure 3. Electrostatic surface potentials of the binding sites of a) min-
iSOG, b) NOX, c) GOX, and d) GR (calculated using Bluues server).
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Considering that the cellular concentration of NADH is in
the 0.1–0.2 mm range,[39] we evaluated the capacity of NOX to
convert 200 mm 1 in the presence of an equimolar quantity of
NADH in PB (Figure S64). NOX naturally uses O2 as an
electron acceptor to generate H2O2 in the presence of
NADH.[27] At such low concentrations, the enzyme consumed
NADH too rapidly, precluding any catalytic conversion of 1.
For this reason, the reaction was studied under N2 atmos-
phere. Accordingly, we determined that NOX could activate
approximately 33% of 1 in the absence of O2, revealing that
flavoenzymes may indeed turn on Pt drug activity under
certain cellular conditions, that is, hypoxia. Although the PtIV
conversion did not reach completion, the concentration of
activated 1 should be sufficient to induce cell death in cancer
tissues.
At higher concentrations of electron donor in aerated
solution, the enzyme reaction pathway is altered by 1, which
effectively competes with O2 and intercepts electrons from
the reduced flavoenzyme. In fact, the activity of NOX
increased by a factor of 2.3 while the production of H2O2
simultaneously decreased (Figure 4a) when 1 mm 1 was
incubated with equimolar NADH. Under these conditions,
the enzyme worked faster because it had access to higher
concentrations of electron acceptors (1 and O2), and pro-
duced lower amounts of H2O2 because the hydride of NADH
ought to be shared between the O2 and metal complex
reduction reactions. Conversely, miniSOG production of
H2O2 is independent of the presence of 1 (Table S1) as it
likely proceeds through photosensitization.[40]
The capability of miniSOG and NOX to act as bioorthog-
onal catalysts towards PtIV prodrugs was investigated by using
1 in cell culture medium, where components such as proteins,
vitamins, and salts can interfere with the activation process.
Reactions in the presence of NADH (2 mm) showed that
miniSOG converted 1 in the biological environment only
under light irradiation while the same reaction occurred
already in the dark with NOX (Figure 4b and Figure S75).
The flavoproteins almost retained the selectivity and effi-
ciency of free FAD under these conditions (Figure S76).
A molecular description of the catalytic mechanism
through which free flavins and flavoproteins activate PtIV
and RuII complexes requires further investigations and is
out of the scope of this manuscript. Our previous study
suggests the catalysis is linked to the generation of the
reduced forms of FAD and FMN (e.g., FADH2 and FMNH2),
either through photoinduced electron transfer (MES) or
hydride transfer (NADH/NADPH). High levels of electron
donors and light help increasing the catalytic efficiency of the
flavins by stabilizing their active species and consequently
enhancing the reaction rates. Metal complexes may form
transient adducts with the reduced flavins and undergo
chemical and photochemical transformations.[11]
Nevertheless, it is clear from the results of this study that
protein scaffolds play a crucial role in governing the metal
substrate access to the flavin catalytic site. Therefore, the
negatively charged electrostatic surface of GOX and the
shielded channel in which its FAD is bound prevent any
interaction with negatively charged 1. Consistently, we
observed that the consumption of glucose by GOX was not
affected by the presence of an equimolar amount of
1 (Table S2). Albeit with poor efficiency, GOX activated 2,
which is in agreement with the absence of charged chemical
groups in the complex and its lower reduction potential
compared to that of 1.[41]
In the case of miniSOG and NOX, however, the protein
scaffold enables the artificial catalysis by facilitating the
formation of reduced FMN/FAD and favoring its stabilization
for the subsequent electron transfer interaction with the PtIV
substrates. Actually, miniSOG and NOX have more solvent-
exposed flavin units and suitable electrostatic surfaces to
allow metal substrates to access the active site. The role
played by the protein scaffold is dramatic for NOX, which is
an enzyme optimized by Nature to transfer hydrides from
NADH to electron acceptors. Consistently, NOX activity
towards 1 and 2 is observed almost instantaneously in the
dark with NADH. On the contrary, miniSOG, a protein
derived from phototropin 2, which naturally does not use
NADH as a cofactor, requires light activation. Similar to
NOX and in contrast to GOX, GR has a mostly neutral FAD
binding pocket, which enables the catalytic activation of 1 and
2. Nonetheless, GR requires light triggering for catalysis likely
owing to the limited accessibility of its FAD with respect to
NOX.
In conclusion, we have shown that free flavins and
flavoproteins can catalyze artificial reactions of PtIV and
RuII complexes, operating either in the dark or upon light
excitation. Some of these unconventional reactions have
promising catalytic efficiency and bioorthogonal selectivity.
Figure 4. a) Catalytic consumption rate of NADH (magenta) and
generation of H2O2 (blue) with NOX measured employing a 1:1 ratio
of 1 and NADH at a concentration of 1 mm. b) Catalytic activity of
NOX in the dark in cell culture medium (pH 7) in the presence of
NADH. 1H NMR spectra were recorded for solutions of 200 mm 1 and
10 mm NOX and 2 mm NADH. 1H NMR signal labeling: ~:
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These findings open new opportunities for the design of
chemically and light-activated metal-based prodrugs, whose
biological effects could be triggered endogenously by bio-
orthogonal flavoprotein catalysts.
Acknowledgements
We thank the Spanish MINECO for grants CTQ2016-80844-
R, BIO2016-77367-C2-1-R, BIO2015-69887-R, and BES-
2013-065642. COST action CM1303 is also acknowledged
for support (F.L.-G.). We also thank the European Research
Council (ERC-CoG-648071-ProNANO, A.L.-C.) for support.
Dr. D. Padrl is acknowledged for his kind support with NMR
experiments.
Conflict of interest
The authors declare no conflict of interest.
Keywords: bioorthogonal chemistry · flavoproteins ·
metal-based prodrugs · photocatalysis · photochemotherapy
How to cite: Angew. Chem. Int. Ed. 2018, 57, 3143–3147
Angew. Chem. 2018, 130, 3197–3201
[1] J. A. Prescher, C. R. Bertozzi, Nat. Chem. Biol. 2005, 1, 13 – 21.
[2] P. K. Sasmal, C. N. Streu, E. Meggers, Chem. Commun. 2013, 49,
1581 – 1587.
[3] T. Vçlker, F. Dempwolff, P. L. Graumann, E. Meggers, Angew.
Chem. Int. Ed. 2014, 53, 10536 – 10540; Angew. Chem. 2014, 126,
10705 – 10710.
[4] A. M. P8rez-Llpez, B. Rubio-Ruiz, V. Sebasti#n, L. Hamilton,
C. Adam, T. L. Bray, S. Irusta, P. M. Brennan, G. C. Lloyd-Jones,
D. Sieger, J. Santamar&a, A. Unciti-Broceta, Angew. Chem. Int.
Ed. 2017, 56, 12548 – 12552; Angew. Chem. 2017, 129, 12722 –
12726.
[5] J. T. Weiss, J. C. Dawson, K. G. Macleod, W. Rybski, C. Fraser, C.
Torres-S#nchez, E. E. Patton, M. Bradley, N. O. Carragher, A.
Unciti-Broceta, Nat. Commun. 2014, 5, 3277.
[6] R. M. Yusop, A. Unciti-Broceta, E. M. V. Johansson, R. M.
S#nchez-Mart&n, M. Bradley, Nat. Chem. 2011, 3, 239 – 243.
[7] J. Clavadetscher, S. Hoffmann, A. Lilienkampf, L. Mackay,
R. M. Yusop, S. A. Rider, J. J. Mullins, M. Bradley, Angew.
Chem. Int. Ed. 2016, 55, 15662 – 15666; Angew. Chem. 2016, 128,
15891 – 15895.
[8] M. I. S#nchez, C. Penas, M. E. V#zquez, J. L. MascareÇas, Chem.
Sci. 2014, 5, 1901 – 1907.
[9] M. Tom#s-Gamasa, M. Mart&nez-Calvo, J. R. Couceiro, J. L.
MascareÇas, Nat. Commun. 2016, 7, 12538.
[10] G. Y. Tonga, Y. Jeong, B. Duncan, T. Mizuhara, R. Mout, R. Das,
S. T. Kim, Y.-C. Yeh, B. Yan, S. Hou, V. M. Rotello, Nat. Chem.
2015, 7, 597 – 603.
[11] S. Alonso-de Castro, E. Ruggiero, A. Ruiz-de-Angulo, E.
Rezabal, J. C. Mareque-Rivas, X. Lopez, F. Lopez-Gallego, L.
Salassa, Chem. Sci. 2017, 8, 4619 – 4625.
[12] L. Gong, Z. Lin, K. Harms, E. Meggers, Angew. Chem. Int. Ed.
2010, 49, 7955 – 7957; Angew. Chem. 2010, 122, 8127 – 8129.
[13] T. C. Johnstone, K. Suntharalingam, S. J. Lippard, Chem. Rev.
2016, 116, 3436 – 3486.
[14] F. Barrag#n, P. Llpez-Sen&n, L. Salassa, S. Betanzos-Lara, A.
Habtemariam, V. Moreno, P. J. Sadler, V. March#n, J. Am. Chem.
Soc. 2011, 133, 14098 – 14108.
[15] S. Betanzos-Lara, L. Salassa, A. Habtemariam, O. Novakova,
A. M. Pizarro, G. J. Clarkson, B. Liskova, V. Brabec, P. J. Sadler,
Organometallics 2012, 31, 3466 – 3479.
[16] S. Betanzos-Lara, L. Salassa, A. Habtemariam, P. J. Sadler,
Chem. Commun. 2009, 6622 – 6624.
[17] A. Habtemariam, C. Garino, E. Ruggiero, S. Alonso-de Castro,
C. J. Mareque-Rivas, L. Salassa, Molecules 2015, 20, 7276 – 7291.
[18] I. Infante, J. M. Azpiroz, N. G. Blanco, E. Ruggiero, J. M.
Ugalde, J. C. Mareque-Rivas, L. Salassa, J. Phys. Chem. C 2014,
118, 8712 – 8721.
[19] D. P. H. M. Heuts, N. S. Scrutton, W. S. McIntire, M. W. Fraaije,
FEBS J. 2009, 276, 3405 – 3427.
[20] R. J. Needham, C. Sanchez-Cano, X. Zhang, I. Romero-Cane-
lln, A. Habtemariam, M. S. Cooper, L. Meszaros, G. J. Clarkson,
P. J. Blower, P. J. Sadler, Angew. Chem. Int. Ed. 2017, 56, 1017 –
1020; Angew. Chem. 2017, 129, 1037 – 1040.
[21] J. J. Soldevila-Barreda, I. Romero-Canelln, A. Habtemariam,
P. J. Sadler, Nat. Commun. 2015, 6, 6582.
[22] S. Bose, A. H. Ngo, L. H. Do, J. Am. Chem. Soc. 2017, 139, 8792 –
8795.
[23] After conversion into their aqua complexes, 4 and 5 formed
DMSO and NADH adducts in PB buffer (Figures S30 and S38).
[24] S. Weber, E. Schleicher, Flavins and Flavoproteins, Springer,
New York, 2014.
[25] S. Dhar, F. X. Gu, R. Langer, O. C. Farokhzad, S. J. Lippard,
Proc. Natl. Acad. Sci. USA 2008, 105, 17356 – 17361.
[26] X. Shu, V. Lev-Ram, T. J. Deerinck, Y. Qi, E. B. Ramko, M. W.
Davidson, Y. Jin, M. H. Ellisman, R. Y. Tsien, PLOS Biol. 2011,
9, e1001041.
[27] J. Rocha-Mart&n, D. Vega, J. M. Bolivar, C. A. Godoy, A.
Hidalgo, J. Berenguer, J. M. Guis#n, F. Llpez-Gallego, BMC
Biotechnol. 2011, 11, 101.
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